Management of Referred Deep Brain Stimulation Failures
نویسندگان
چکیده
منابع مشابه
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.
BACKGROUND Since the Food and Drug Administration approved DBS, there has been a surge in the number of centers providing the procedure. There is currently no consensus regarding appropriate screening procedures, necessary training of individuals providing the therapy, the need for an interdisciplinary team, or guidelines for the management of complications. An increasing number of patients com...
متن کاملO10: Deep Brain Stimulation and Psychiatry
The use of deep brain stimulation in psychiatric disorders has received great interest owing to the small risk of the operation, the reversible nature of the technique, and the possibility of optimizing treatment postoperatively. Currently deep brain stimulation in psychiatry is investigated for obsessive-compulsive disorder, Gilles de la Tourette’s syndrome and major depression. This presentat...
متن کاملo10: deep brain stimulation and psychiatry
the use of deep brain stimulation in psychiatric disorders has received great interest owing to the small risk of the operation, the reversible nature of the technique, and the possibility of optimizing treatment postoperatively. currently deep brain stimulation in psychiatry is investigated for obsessive-compulsive disorder, gilles de la tourette’s syndrome and major depression. this presentat...
متن کاملManagement of Elevated Therapeutic Impedances on Deep Brain Stimulation Leads
CLINICAL VIGNETTE A 64-year-old male with a history of essential tremor with bilateral thalamic ventralis intermedius deep brain stimulation implants had elevated therapeutic impedance values despite normal lead integrity impedances and good response to stimulation. CLINICAL DILEMMA Do elevated therapeutic impedance values indicate a sign of hardware malfunction? What are the guidelines to ap...
متن کاملPost-Operative Management of Parkinson Patients with Deep Brain Stimulation
Oral medication still remains the mainstay for treating Parkinson’s disease (PD). Since the introduction in the late 60ies levodopa is regarded as the gold standard because of the best efficacy on akinesia and rigidity compared to other drugs like dopamine agonists or anticholinergics (Poewe et al., 2010). However, oral dopaminergic treatment of motor symptoms is complicated by the development ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Neurology
سال: 2005
ISSN: 0003-9942
DOI: 10.1001/archneur.62.8.noc40425